The 78-year-old Adelson, who is a medical doctor, will retain 51.3% of company shares following the sale, according to the filing.
If the entirety of the $2 billion goes toward the purchase, it would mean Adelson could be acquiring at least 57% of the NBA team - based on the $3.5 billion valuation.
